Thymosin Alpha-1: How This Peptide Helps Guide the Immune System
This article is a reader-friendly summary of the scientific review “Thymosin α1 and Its Role in Viral Infectious Diseases: The Mechanism and Clinical Application,” published in the journal Molecules in 2023. Thymosin Alpha-1, often shortened to Tα1, is a small peptide that has been studied for the way it interacts with the immune system. Instead […]
Retatrutide Reconstitution: A Research Guide to Concentration, Mixing, Storage, and Handling
Buy Retatrutide: 20mg GLP3-R 30mg GLP-R Retatrutide has become a major subject of metabolic research because of its unusual pharmacological design. Unlike compounds that primarily target a single incretin pathway, retatrutide is being investigated as a triple receptor agonist with activity at the GLP-1, GIP, and glucagon receptors. As interest in the compound has […]
Could a Mitochondrial Peptide Become a New Target in Ovarian Cancer Research?
A summary of Mitochondrial-derived peptide MOTS-c suppresses ovarian cancer progression through the USP7/LARS1 axis. Advanced Science (2025) For years, scientists have known that mitochondria do much more than produce energy. They’re increasingly recognized as key regulators of aging, metabolism, inflammation, and even cancer. One of the most intriguing molecules to emerge from mitochondrial research is […]
SS-31: Could Protecting Your Mitochondria Be the Key to Healthier Kidneys?
Scientists are discovering that one tiny peptide may help preserve the body’s cellular power plants—and protect the kidneys from damage. When most people think about kidney disease, they think about blood pressure, diabetes, or aging. Researchers, however, are increasingly looking somewhere much smaller. Inside the mitochondria. These microscopic structures are often called the powerhouses of […]
FDA Pharmacy Compounding Advisory Committee Recommends Six Peptides: What Researchers Need to Know
The U.S. Food and Drug Administration’s (FDA) Pharmacy Compounding Advisory Committee (PCAC) has concluded its review of seven peptide substances, recommending that six move forward for consideration on the FDA’s 503A Bulks List. For researchers, compounding pharmacies, and others following peptide science, the meeting represented one of the most closely watched regulatory discussions in recent […]
Glutathione: The Master Antioxidant at the Center of Healthy Aging, Cellular Defense, and Tissue Regeneration
A Scientific Review of Nearly 200 Studies Reveals Why Glutathione Continues to Shape Regenerative Medicine Every second, billions of cells throughout the body are exposed to oxidative stress—a natural consequence of metabolism, environmental exposures, and aging. Left unchecked, oxidative damage can affect DNA, proteins, cellular membranes, and even the mitochondria responsible for producing the energy […]
NAD⁺ Supplementation: What Does the Science Really Say About Healthy Aging?
Can raising your body’s NAD⁺ levels actually slow aging—or is the science still catching up to the hype? A comprehensive review of more than 100 scientific studies provides one of the clearest answers yet. The Growing Interest in NAD⁺ Over the past several years, NAD⁺ (Nicotinamide Adenine Dinucleotide) has become one of the most talked-about […]
Can Peptide Bioregulators “Turn On” Age-Related Genes?
A Summary of Anti-aging peptide bioregulators induce reactivation of chromatin (2006) One of the most intriguing theories in aging research is that many of our genes don’t disappear as we get older—they simply become less active. This study explored whether several well-known peptide bioregulators could “wake up” these inactive genes in elderly individuals. Researchers examined […]
Livagen and DNA: A Simple Review of a Classic Scientific Study
Understanding the Science Behind Livagen At Crownwell Research, we believe scientific research should be understandable—not just for scientists, but for anyone interested in learning. This article is a simplified review of a published scientific study examining how the peptide bioregulator Livagen may influence DNA activity inside cells. Rather than repeating the technical language used in […]
Clinical Trial Readiness Starts with Reliable Research Data
Clinical trials are built on evidence. Before a study can move into a clinical setting, researchers need strong, consistent, and well-documented data from earlier stages of investigation.That process begins with reliable laboratory research.Why Early Research Data MattersEvery clinical development pathway depends on informed decision-making. Researchers must understand the compound being studied, the systems it may […]